Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
inhibitor | agent reducing activity of a specified enzyme or transporter | The new prescription is listed as an inhibitor of the metabolic pathway under review. | Assessment | Medication exposure, response and adverse-effect reasoning |
inhibitor pattern | clotting abnormality with findings suggesting an inhibitor | The inhibitor pattern persisted after incubation in the mixing study. | Objective | Coagulation, antibodies and hemostasis studies |
minimum inhibitory concentration | lowest tested concentration inhibiting visible growth under standard conditions | The isolate's minimum inhibitory concentration is reported in mg/L. | Objective | Microbiology and specimen interpretation |
antithrombin activity | functional measure of the plasma inhibitor antithrombin | Antithrombin activity was interpreted with the timing of the acute thrombosis. | Objective | Coagulation, antibodies and hemostasis studies |
AUC/MIC | drug exposure divided by the organism's minimum inhibitory concentration | The consult reports AUC/MIC and states the MIC and method used. | Assessment | Drug levels - exposure and pharmacokinetics |
Bethesda titer | measure of the activity of a specific clotting factor inhibitor | The Bethesda titer was supplied with the method and units. | Objective | Coagulation, antibodies and hemostasis studies |
everolimus | mTOR inhibitor with indication-specific monitoring considerations | The everolimus trough is documented with the transplant team's stated target. | Objective | Drug levels - named analytes and exposure reports |
lupus anticoagulant assay | phospholipid-dependent testing for a circulating inhibitor | The lupus anticoagulant assay was reviewed with the current anticoagulant exposure. | Objective | Coagulation, antibodies and hemostasis studies |
sirolimus | mTOR inhibitor monitored using whole-blood concentrations in specified settings | The sirolimus report states whole blood and the collection time. | Objective | Drug levels - named analytes and exposure reports |
minimum bactericidal concentration | lowest concentration meeting the assay's defined bacterial killing endpoint | The minimum bactericidal concentration was listed separately from the minimum inhibitory concentration. | Objective | Molecular testing, serology and culture findings |